A major breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This vital malignant suppressor protein is frequently disabled in various forms of cancer, leading https://whitebookmarks.com/story22032214/nanobodies-reactivate-the-p53-protein-the-promising-pathway-for-cancer-management